Damian Gawel
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Abrogation of SOS mutagenesis by the E. coli OxyR oxidative stress response.
Journal: mSystems
Published: March 30, 2026
Selective Estrogen Receptor Modulators' (SERMs) Influence on TET3 Expression in Breast Cancer Cell Lines with Distinct Biological Subtypes.
Journal: International journal of molecular sciences
Published: May 31, 2024
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment.
Journal: Biomedicines
Published: May 31, 2024
Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing.
Journal: Computational and structural biotechnology journal
Published: April 18, 2023
Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
Journal: ACS biomaterials science & engineering
Published: September 29, 2022
Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis.
Journal: Biomedicines
Published: January 24, 2022
Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update.
Journal: International journal of molecular sciences
Published: September 27, 2021
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193mPt and 195mPt Radionuclides in Auger Electron Therapy.
Journal: Molecules (Basel, Switzerland)
Published: March 15, 2021
Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis.
Journal: Diagnostics (Basel, Switzerland)
Published: February 15, 2021
The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 15, 2021
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy.
Journal: Nanomaterials (Basel, Switzerland)
Published: September 18, 2020
Last Updated: 09/26/2026